Tag: generics

October 14, 2018

10 Drugs Going Off Patent in 2018

A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
May 3, 2018

Notes from the Floor: Bloom Burton & Co., Day 2

The Bloom Burton & Co. Healthcare Investor Conference was held from May 2 to 3 in Toronto — here’s what...
April 17, 2018

Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi’s European generics business

Advent International and Sanofi (EURONEXT:SAN) (NYSE:SNY) have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics...
February 13, 2018

Cancer Therapies to Reach $26.61 billion by 2025, Report Says

A new report by Grandview Research suggests that global novel drug delivery systems (NDDS) in cancer therapies will reach $26.61...
September 20, 2017

Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release

Elite Pharmaceuticals filed an abbreviated new drug application with the FDA for a generic version of OxyContin.
July 31, 2017

Generic Drugs Lead the FDA's Competition Action Plan

On his first three months as commissioner of the Food and Drug Administration, Scott Gottlieb has already taken significant steps...
July 5, 2017

Endo Will Divest Grupo Farmacéutico SOMAR

Endo International plc will sell Mexico City-based Grupo Farmacéutico SOMAR for close to $124 million to Advent International.